Trump’s FDA Nominee Overton Faces Senators’ Questions on Vaccines, Abortion Pills and Whether She Can Tell the President He’s Wrong

President Trump has nominated Dr. Heidi Overton to lead the Food and Drug Administration, and senators spent two hours asking her whether she can tell the president he is wrong. The hearing covered abortion pills, vaccines, autism and recent food poisoning outbreaks, but the central question was simple: can a regulator disagree with the boss?

Overton answered carefully throughout the session. When Senator Maggie Hassan, a Democrat from New Hampshire, asked her three times whether the president could be wrong, Overton said the president sets policy directions but works with advisers to get the best information and wants to make the best decision in the best interest of Americans.

The Questions From Senators

Senator Bill Cassidy, a Republican from Louisiana, pressed Overton on the MMR vaccine. During a press conference in the Oval Office, the president called the vaccine potentially quite lethal without evidence. Overton affirmed that the MMR vaccine is not lethal, safe and effective.

She also said the MMR vaccine is the best public health tool to fight the ongoing measles outbreak. When asked if she disagreed with the president, Overton did not answer directly but affirmed her duty to uphold FDA laws and regulations for safety and efficacy.

A 2023 paper Overton wrote at the conservative America First Policy Institute calling mifepristone dangerous came up several times. Overton said that according to the FDA, mifepristone is safe and effective.

Pressed whether she still believed the drug was dangerous, Overton said she could not prejudge whether the drug’s label should be changed because the agency is doing another safety review. That review was first announced a year ago and is ongoing.

The Key Facts

• Hearing lasted around two hours
• Senator Maggie Hassan asked Overton three times whether the president could be wrong
• Senator Bill Cassidy asked about the MMR vaccine at a press conference in the Oval Office
• A 2023 paper Overton wrote at America First Policy Institute called mifepristone dangerous
• The FDA safety review of mifepristone was first announced a year ago and is ongoing

Overton did not answer directly when asked if she disagreed with the president. Instead she affirmed her duty to uphold FDA laws and regulations for safety and efficacy.

Where the paper stands

The paper backs Dr. Heidi Overton’s right to serve as FDA commissioner without fear of political retribution and is against any system that would force a public official to agree with the president rather than the science. The FDA exists to protect consumers from unsafe drugs and devices, and its judgment must rest on evidence, not loyalty tests.

The hearing showed Overton willing to defend scientific consensus on vaccines and abortion pills, even when senators pressed her to reject the president’s statements outright. That is the kind of courage the FDA needs. But the fact that senators had to ask these questions at all — and that the nominee felt compelled to affirm her duty to FDA laws rather than simply state the science — shows a system under strain.

The paper would prefer a nomination process where candidates are judged on their qualifications and record, not on whether they will publicly defy the person who appointed them. Until then, Overton deserves credit for answering honestly and standing firm on the science.

Source material: “President Trump's FDA commissioner nom, Dr. Heidi Overton, faces Senators' questions,” NPR.

abortion pills · FDA · Heidi Overton · Trump · vaccines